EDITORIAL SECTION
-
STRATEGY
Smarter Pharma
Quality management systems QMS are the backbone of pharmaceutical manufacturing ensuring safe products
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solution
-
CLINICAL TRIALS
Why Clinical Trials Need Digital Endpoints
According Citeline the average success rate for bringing a Phase candidate to market has dropped to an alltime low of just
-
MANUFACTURING
Ensuring Quality and Compliance in Biopharma
Ensuring quality and regulatory compliance in the biopharmaceutical industry is critical to safeguarding product safety and efficacy
-
Information Technology
The Cost of Bad Data
Modern pharmaceutical research generates an unprecedented volume of information Data from genomic sequencing
-
Biopharma
Reimagining Global Biomanufacturing Capacity with Continuous and Modular Systems
Biotechnology is fueling the ongoing expansion of the global market for a broad array of goods
-
EXPERT Talk
From Compliance to Competitive Advantage
Compliance gets you through an audit Resilience gets medicines to patients on the day something unexpected happens The DSCSAs enhanced requirements took effect November but real interoperability required three more rounds of accommodation phased implementation with the smalldispenser
Advisory Board
KNOWLEDGE BANK
-
Articles
Therapeutic Intervention of Polymeric Nanoparticles Combining Bone Marrow Stem Cells for the treatment of Alzheimer’s disease
Alzheimers disease ADis a neurological disorder that is responsible for brain atrophy and neuronal degeneration resulting in a decline in thinking ability and behaviour The progressive neurodegeneration leads to memory loss or dementia which makes it difficult to carry out daytoday tasks and it also has an impact on the socializing ability of the individual
What Are the Implications of the Changing Regulatory Landscape in Europe?
In an age characterized by technological progress changing geopolitical scenarios and an increasing focus on sustainability businesses in Europe are grappling with an intricate network of regulatory shifts
Unlocking New Therapies: How Generative AI Enhances Drug Discovery
Drug discovery is a highly complex process that used to be very timeconsuming a decade or more for the entire project However Generative AI or Artificial Intelligence has brought significant shifts in the sector
How to Mitigate Operational Risks in the Pharma Industry?
The operation of the pharmaceutical industry has significant risks with the most probable being operational risks These risks include supply chain interruption regulatory non compliance product defects technological disruption The development of strategies to avoid compromise in operations remains paramount not only in protecting the customers from harm or receiving
Medical Devices and Pharma: A Symbiotic Relationship for Improved Healthcare
The healthcare industry is continually evolving driven by technological advancements and innovative approaches to patient care Among the most significant developments is the symbiotic relationship between medical devices
Achieving Full Digital Maturity in Pharma Manufacturing: A Paperless Transformation Guide
The pharmaceutical sector is changing radically as manufacturers do not rely on the past and dataintensive processes The vision of paperless pharma manufacturing is not a dream anymore it is a strategy based on the pressure of the regulators the complexity of operations and the need to accomplish faster and with accuracy production The center of this change is the digital pharma manufacturing and...
-
Techno Trends
FDA Grants Breakthrough Therapy Designation to Calico's Fosigotifator
Calico Life Sciences LLC has announced that the US Food and Drug Administration FDA has granted Breakthrough Therapy Designation to fosigotifator for the treatment of Vanishing White Matter disease a rare and progressive neurological disorder with no approved therapies
-
Projects
Johnson & Johnson Invests $1B to Expand U.S. Vision Manufacturing & Distribution
Johnson Johnson has announced an investment of more than billion to expand its Vision manufacturing operations in Jacksonville Florida The project is designed to increase domestic manufacturing packaging and distribution capacity for the company
-
Research Insights
A genomic-led strategy to anticipate drug safety effects
Safetyrelated issues account for approximately of failures in new drug discovery programs On top of that many are discovered during postmarketing surveillance
-
whitepaper
Placing the Right Bets: Defining Tailored Investment Strategies for Pharma Launch
Pharmaceutical launches have become significantly harder to execute successfully As IQVIAs new white paper highlights median six month cumulative sales for innovative launches have declined by compared with pre levels reflecting shrinking market opportunities
TOP ARTICLES
-
1
What Are the Implications of the Changing Regulatory Landscape in Europe?
Kate Williamson
The changing regulatory landscape in Europe, spanning data protection, digital services, climate action, finance, healthcare, Brexit impact, consumer protection, AI ethics, taxation, and telecommunica...
-
2
Unlocking New Therapies: How Generative AI Enhances Drug Discovery
Kate Williamson
The age of Generative AI is a major shift in drug discovery through speeding up development and improving the efficiency. This article is going to provide us with a critical analysis of how Generative...
-
3
How to Mitigate Operational Risks in the Pharma Industry?
Kate Williamson
This article also considers the possible solutions and recommendations for organizations which planning to minimize the operational risks as for the general field and in the context of pharmaceuticals...
-
4
Medical Devices and Pharma: A Symbiotic Relationship for Improved Healthcare
Kate Williamson
The symbiotic relationship between medical devices and pharmaceuticals revolutionizes healthcare by enhancing diagnostics, treatment, and disease management. This integration fosters personalized medi...
-
5
Achieving Full Digital Maturity in Pharma Manufacturing: A Paperless Transformation Guide
Kate Williamson
This article discusses how paperless pharma production is achieved to realize complete digital maturity, through automation, compliance-sourced software and integrated digital systems. It shows the ad...
press releases Read more...
Johnson & Johnson Announces Collaboration with Sail Biomedicines to Advance in vivo CAR-T Programs and Transform Autoimmune Disease Through Immune Reset
Johnson Johnson NYSE JNJ today announced strategic agreements and collaboration with Sail Biomedicines Sail a biotechnology company developing in vivo CART therapies for immunemediated diseases
AbCellera Announces Collaboration with Vertex to Discover Multispecific T-Cell Engagers for Autoimmune Diseases and Other Conditions
AbCellera Nasdaq ABCL today announced a collaboration with Vertex Pharmaceuticals Incorporated Nasdaq VRTX to research develop manufacture and commercialize multispecific Tcell engagers
Evinova Launches Strategic Partnership with Merck KGaA, Darmstadt, Germany to Define the Future of Clinical Development
Evinova a global leader in AInative clinical development technology today announced a new multiyear strategic collaboration to accelerate global clinical development with Merck KGaA Darmstadt Germany
Clean Cells acquires Anaquant to expand analytical capabilities in biomanufacturing quality control
Clean Cells a leading biopharmaceutical quality control services provider specializing in biologics GMP testing and a member of the Clean Biologics Group today announces its acquisition of Anaquant
Events Read more...
26 - 30
Jul 2026ADLM 2026
Anaheim, CA USA
28 - 30
Jul 20265th In Vivo Cell & Gene Summit 2026
500 Commonwealth Avenue, Bosto...
03 - 04
Aug 2026Clinical Pharmacology and Toxicology 2026
Dubai, UAE
11 - 12
Aug 2026Medical Device Safety Monitoring and Reporting
San Diego, CA, USA
19 - 21
Aug 2026ISPE Conference & Exhibition 2026
Suntec Singapore
20 - 21
Aug 2026Pharmaceutical Formulations 2026
London, UK
20 - 21
Aug 2026Novel Drug Delivery Systems 2026
London, UK
20 - 21
Aug 2026Advanced Clinical Research 2026
London, UK
LATEST NEWS Read more...
Allogene Therapeutics Gains FDA RMAT and Fast Track Status for Cema-Cel in First-Line Large B-Cell Lymphoma
Allogene Therapeutics has received Regenerative Medicine Advanced Therapy RMAT and Fast Track designations from the US Food and Drug Administration FDA for its investigational allogeneic CAR T therapy
Ocugen Receives FDA RMAT Designation for OCU410 in Geographic Atrophy
Ocugen has received Regenerative Medicine Advanced Therapy RMAT designation from the US Food and Drug Administration FDA for its investigational gene therapy OCU for the treatment of geographic atrophy
Eton Pharmaceuticals Seeks FDA Approval to Expand KHINDIVI Use in Younger Children
Eton Pharmaceuticals has submitted a Prior Approval Supplement PAS to the US Food and Drug Administration FDA seeking to expand the approved use of KHINDIVI hydrocortisone oral solution
Dyne Therapeutics Receives FDA Clearance to Begin Phase 1 Trial of DYNE-302 for FSHD
Dyne Therapeutics has received clearance from the US Food and Drug Administration FDA for its Investigational New Drug IND application to begin a Phase clinical trial of DYNE for the treatment of facioscapulohumeral
Antag Therapeutics Doses First Patient in Phase 2a Trial of AT7687 for Obesity and Type 2 Diabetes
Antag Therapeutics has dosed the first participant in its Phase a clinical trial evaluating AT a firstinclass glucosedependent insulinotropic polypeptide receptor GIPR antagonist in combination
HAYA Therapeutics Receives FDA Fast Track Designation for HTX-001 in Non-Obstructive Hypertrophic Cardiomyopathy
HAYA Therapeutics has received Fast Track designation from the US Food and Drug Administration FDA for HTX its investigational therapy for the treatment of symptomatic nonobstructive hypertrophic cardiomyopathy nHCM




